DE602005020811D1 - Vorrichtung für die transdermale abgabe von wirkstoffen - Google Patents

Vorrichtung für die transdermale abgabe von wirkstoffen

Info

Publication number
DE602005020811D1
DE602005020811D1 DE602005020811T DE602005020811T DE602005020811D1 DE 602005020811 D1 DE602005020811 D1 DE 602005020811D1 DE 602005020811 T DE602005020811 T DE 602005020811T DE 602005020811 T DE602005020811 T DE 602005020811T DE 602005020811 D1 DE602005020811 D1 DE 602005020811D1
Authority
DE
Germany
Prior art keywords
active substances
layer
transdermal distribution
transdermal
water
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602005020811T
Other languages
English (en)
Inventor
Paolo Colombo
Patrizia Santi
Sara Nicoli
Cristina Padula
Fabio Marra
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lisapharma SpA
Original Assignee
Lisapharma SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34956372&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE602005020811(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lisapharma SpA filed Critical Lisapharma SpA
Publication of DE602005020811D1 publication Critical patent/DE602005020811D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE602005020811T 2004-07-23 2005-07-22 Vorrichtung für die transdermale abgabe von wirkstoffen Active DE602005020811D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT001492A ITMI20041492A1 (it) 2004-07-23 2004-07-23 Nuovo dispositivo per il rilascio di principi attivi
PCT/EP2005/053581 WO2006008320A2 (en) 2004-07-23 2005-07-22 Device for transdermal delivery of active principles

Publications (1)

Publication Number Publication Date
DE602005020811D1 true DE602005020811D1 (de) 2010-06-02

Family

ID=34956372

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005020811T Active DE602005020811D1 (de) 2004-07-23 2005-07-22 Vorrichtung für die transdermale abgabe von wirkstoffen

Country Status (9)

Country Link
US (1) US20080292684A1 (de)
EP (1) EP1789025B1 (de)
JP (1) JP2008507495A (de)
AT (1) ATE464888T1 (de)
CA (1) CA2574682A1 (de)
DE (1) DE602005020811D1 (de)
ES (1) ES2344912T3 (de)
IT (1) ITMI20041492A1 (de)
WO (1) WO2006008320A2 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7629384B2 (en) * 1997-09-17 2009-12-08 Strategic Science & Technologies, Llc Topical delivery of L-arginine to cause beneficial effects
US9226909B2 (en) 2004-04-19 2016-01-05 Strategic Science & Technologies, Llc Beneficial effects of increasing local blood flow
JP2007532697A (ja) 2004-04-19 2007-11-15 ストラテジック サイエンス アンド テクノロジーズ， エルエルシー 局所的血流増大の有益な効果
US20070264487A1 (en) * 2006-05-12 2007-11-15 Dean Georgiades Treated film strips
US20090297591A1 (en) * 2008-05-30 2009-12-03 Orient Pharma Co., Ltd. Compositions And Methods For The Transdermal Delivery Of Pharmaceutical Compounds
US11684624B2 (en) * 2009-06-24 2023-06-27 Strategic Science & Technologies, Llc Treatment of erectile dysfunction and other indications
US9072659B2 (en) 2009-06-24 2015-07-07 Strategic Science & Technologies, Llc Topical composition containing naproxen
AU2009348470B2 (en) 2009-06-24 2015-04-02 Strategic Science & Technologies, Llc Topical composition containing ibuprofen
US20230372351A1 (en) * 2009-06-24 2023-11-23 Strategic Science & Technologies, Llc Treatment of erectile dysfunction and other indications
EP2658551B1 (de) * 2010-12-29 2020-07-01 Strategic Science & Technologies, LLC Behandlung von erektionsstörungen und anderen indikationen
US9289495B2 (en) 2010-12-29 2016-03-22 Strategic Science & Technologies, Llc Systems and methods for treatment of allergies and other indications
EP2697492B1 (de) 2011-04-11 2017-09-27 Alliqua, Inc. Transdermale pflaster mit durch ionisierte strahlung vernetzten polymeren und verbesserten freisetzungseigenschaften
ITMI20111355A1 (it) * 2011-07-20 2013-01-21 Epifarma Srl Cerotto transdermico contenente diclofenac e tiocolchicoside
SG11201400167VA (en) * 2011-08-25 2014-06-27 Nipro Patch Co Ltd Hydrous adhesive skin patch
JP5307931B1 (ja) * 2012-12-27 2013-10-02 久光製薬株式会社 貼付剤及びその製造方法
EP2968652B1 (de) 2013-03-13 2020-07-22 Avery Dennison Corporation Verbesserung von hafteigenschaften
CN104758181A (zh) * 2015-04-09 2015-07-08 史祎 一种无溶剂贴敷剂制备工艺
WO2018006069A1 (en) * 2016-06-30 2018-01-04 Teva Pharmaceuticals International Gmbh Improved formulations for transdermal pharmaceutical systems
SG11201908061SA (en) * 2017-03-08 2019-09-27 Baxter Int Device for delivery of powdered hemostatic agents
US11510882B2 (en) 2017-09-22 2022-11-29 Medrx Co., Ltd. Non-readherable adhesive patch
EP3999032A4 (de) 2019-07-16 2023-08-30 Donaghys Limited Transdermales lösungsmittelsystem und verwendungsverfahren
KR20220121350A (ko) * 2021-02-25 2022-09-01 한국원자력연구원 항암 효과를 갖는 하이드로겔 및 이의 제조방법

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3827561C1 (de) * 1988-08-13 1989-12-28 Lts Lohmann Therapie-Systeme Gmbh & Co Kg, 5450 Neuwied, De
DE3933460A1 (de) * 1989-10-06 1991-04-18 Lohmann Therapie Syst Lts Oestrogenhaltiges wirkstoffpflaster
JPH07265352A (ja) * 1994-03-31 1995-10-17 Sekisui Chem Co Ltd 貼付剤
IT1319210B1 (it) * 2000-10-13 2003-09-26 Italiano Biochimico Lisapharma Pellicola per la somministrazione dermica e transdermica di principiattivi.
US20050113510A1 (en) * 2001-05-01 2005-05-26 Feldstein Mikhail M. Method of preparing polymeric adhesive compositions utilizing the mechanism of interaction between the polymer components
US6887291B2 (en) 2001-08-30 2005-05-03 Tda Research, Inc. Filter devices and methods for carbon nanomaterial collection

Also Published As

Publication number Publication date
CA2574682A1 (en) 2006-01-26
WO2006008320A3 (en) 2006-05-04
ATE464888T1 (de) 2010-05-15
JP2008507495A (ja) 2008-03-13
ITMI20041492A1 (it) 2004-10-23
US20080292684A1 (en) 2008-11-27
ES2344912T3 (es) 2010-09-09
EP1789025B1 (de) 2010-04-21
WO2006008320A2 (en) 2006-01-26
EP1789025A2 (de) 2007-05-30

Similar Documents

Publication Publication Date Title
DE602005020811D1 (de) Vorrichtung für die transdermale abgabe von wirkstoffen
AR048878A1 (es) Composiciones topicas de metadona y metodos para usarlas
WO2007070649A3 (en) Antimicrobial coating system
AR097045A2 (es) Sistema terapéutico transdérmico
ATE554804T1 (de) Verfahren zur herstellung von beschichteten medizinischen vorrichtungen
ATE431130T1 (de) Verwendung einer äusseren rückschicht zur herstellung eines implantierbaren pflasters zur arzneistoffabgabe
WO2007011612A3 (en) Wound dressing and methods of making and using the same
HK1108350A1 (en) Cooling topical patch preparation
MEP23508A (en) Compositions and methods for comtrolling drug loss and delivery in transdermal drug delivery systems
TW200614971A (en) Absorbent article
ATE369825T1 (de) Wundauflage
ATE481118T1 (de) Hydrophiler überzug mit einem polyelektrolyten
MY144351A (en) Gel adhesive compositions, method of making, and use thereof
DE60204158D1 (de) Beschichtungen mit immobilisierten partikeln sowie verwendungen derselben
DE69923675D1 (de) Pharmazeutische trägervorrichtung welche zur verabreichung von wirkstoffen an schleimhautoberflächen geeignet ist
NZ588883A (en) Permeant delivery system and methods for use thereof
WO2009097508A3 (en) Methods and compositions for wound healing
DE602005001765D1 (de) Kapillarmoderator in einem osmotischen abgabesystem zur prävention von rückfluss in das wirkstoffreservoir
WO2008005458A3 (en) Delivery device having self-assembling dendritic polymers and method of use thereof
ATE389385T1 (de) Ophthalmische depot-formulierungen zur periokkularen oder subkonjunktivalen verabreichung
WO2007130841A3 (en) Oral compositions comprising siloxane polymers
DE502005004881D1 (de) Trennschichtträger
TW200514590A (en) Hydrophilic adhesives for delivery of herbal medicines
BRPI0411752A (pt) implantes subcutáneos apresentando liberação inicial limitada do princìpio ativo e liberação ampliada subseqüente linearmente variável do mesmo
EP1686162A3 (de) Herstellung eines Klebebandes

Legal Events

Date Code Title Description
8363 Opposition against the patent